Table 3.
Distribution of patients and association between the sum of low-activity alleles in the XRCC1 gene and survival (only chemotherapy treated patients (intravescical + systemic)
| Deceased of cancer N | Alive N | HR crude (95% CI) | HR adjusted (95% CI)1 | |
| 0 XRCC1 variant alleles | 9 | 15 | Ref | Ref |
| 1 XRCC1 variant allele | 8 | 18 | 0.71 (0.27–1.85) | 0.39 (0.12–1.26) |
| 2–4 XRCC1 variant alleles | 5 | 15 | 0.50 (0.17–1.50) | 0.28 (0.08–1.18) |
| >4 XRCC1 variant alleles | 3 | 16 | 0.35 (0.94–1.29) | 0.05 (0.01–0.34) |
1
Adjusted for age, smoking status, stage and grading.